PharmaCielo Ltd. (TSXV:PCLO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0450
0.00 (0.00%)
Aug 5, 2025, 1:28 PM EST
-62.50%
Market Cap 8.46M
Revenue (ttm) 2.27M
Net Income (ttm) -6.56M
Shares Out 187.98M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 74,615
Average Volume 68,007
Open 0.0500
Previous Close 0.0450
Day's Range 0.0450 - 0.0500
52-Week Range 0.0250 - 0.2300
Beta 0.73
RSI 44.65
Earnings Date Dec 1, 2025

About PharmaCielo

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. PharmaCielo Ltd. is headquartered ... [Read more]

Sector Healthcare
CEO Marc Lustig
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol PCLO
Full Company Profile

Financial Performance

In 2024, PharmaCielo's revenue was 3.17 million, a decrease of -8.81% compared to the previous year's 3.48 million. Losses were -9.10 million, -0.50% less than in 2024.

Financial Statements

News

There is no news available yet.